Nova Eye Medical

US Market Dependence Will Constrain Earnings But Enable Novel Approaches

AnalystLowTarget

Not Invested

Consensus Narrative from 3 Analysts

Published

03 Sep 25

AnalystLowTarget's Fair Value

AU$0.26

36.5% undervalued

03 Sep

AU$0.17

-2.9%

15.8%

-2.9%

15.8%

You can edit this narrative until Sep 3 10:12 PM. Then, changes will post as Updates.

Author's Valuation

AU$0.3

36.5% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

AU$0.26

36.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

21.95%

Medical Equipment revenue growth rate

0.40%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.14%

Calculation

AU$15.01m

Earnings '28

11.61x

PE Ratio '28

AU$174.23m

Market Cap '28

AU$174.23m

Market Cap '28

543.35m

No. shares '28

AU$0.32

Share Price '28

AU$0.32 Share Price '28

Discounted to 2025 @ 7.24% p.a.

AU$0.26

Fair Value '25